Zhenzhen Zhou Selected Research

Neoplasms (Cancer)

7/2023	Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies.
1/2023	Reconstruction of tumor microenvironment viain vitrothree-dimensional models.
1/2022	Scalable Formation of Highly Viable and Functional Hepatocellular Carcinoma Spheroids in an Oxygen-Permeable Microwell Device for Anti-Tumor Drug Evaluation.
10/2021	GINS Complex Subunit 2 Facilitates Gastric Adenocarcinoma Proliferation and Indicates Poor Prognosis.
12/2019	Propofol suppresses proliferation, invasion, and migration of human melanoma cells via regulating microRNA-137 and fibroblast growth factor 9.
10/2015	Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion.
9/2015	mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
3/2015	The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1.
6/2014	Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness.
6/2012	Expression of metadherin/AEG-1 gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenzhen Zhou Research Topics

Disease

10	Neoplasms (Cancer) 07/2023 - 06/2012
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
2	Schizophrenia (Dementia Praecox) 02/2024 - 11/2023
2	Catalepsy 02/2024 - 11/2023
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2014
1	Cognitive Dysfunction 02/2024
1	Hematoma 01/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Necrosis 01/2022
1	Adenocarcinoma 10/2021
1	Melanoma (Melanoma, Malignant) 12/2019
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Thyroid Neoplasms (Thyroid Cancer) 09/2017
1	Papillary Thyroid Cancer 01/2017
1	Nodular Goiter 01/2017
1	Hypoxia (Hypoxemia) 06/2014
1	Liver Neoplasms (Liver Cancer) 01/2014
1	Hepatitis B 06/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2012
2	Trace amine-associated receptor 1IBA 02/2024 - 11/2023
2	AminesIBA 02/2024 - 11/2023
2	bisphenol AIBA 09/2017 - 01/2017
2	IodineIBA 09/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2015 - 09/2015
1	Antipsychotic Agents (Antipsychotics)IBA 02/2024
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2022
1	CytokinesIBA 01/2022
1	baysilon (polydimethylsiloxane)IBA 01/2022
1	carbonic anhydrase XIVIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	CarcinogensIBA 10/2021
1	Fibroblast Growth Factor 9IBA 12/2019
1	Propofol (Diprivan)FDA LinkGeneric 12/2019
1	Intravenous AnestheticsIBA 12/2019
1	diisopropanolnitrosamineIBA 09/2017
1	Estrogen Receptor alphaIBA 09/2017
1	Matrix Metalloproteinase 13IBA 10/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2015
1	Monoclonal AntibodiesIBA 09/2015
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	Histidine (L-Histidine)FDA Link 03/2015
1	Calcium-Binding ProteinsIBA 03/2015
1	Netrin-1IBA 06/2014
1	Chemokine ReceptorsIBA 01/2014
1	LigandsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	InterferonsIBA 06/2012

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2021
1	Immunotherapy 07/2023
1	Radiofrequency Ablation 01/2023